HyperSpectral Raises $7M in Oversubscribed Series A-2 Round to Accelerate Growth
Summary
HyperSpectral closed a $7M oversubscribed Series A-2 round to accelerate product development and prepare for a Series B in 2026. The company also named Dr. Chuck Mattera as Chairman of the Board, adding experienced leadership from the photonics and manufacturing sectors. HyperSpectral plans to expand partnerships and scale into biotech, industrial, and defense markets. Its AI-powered spectral intelligence platform combines spectroscopy with proprietary data to detect pathogens quickly and without specialized lab preparation.
Funding
Amount
$7.0M
Total raised
Date
October 7, 2025
Announcement date
Investors
Kibo Ventures, RRE Ventures
Lead investors
Company
hyperspectral.ai
Funded company
Classifications
industries
HealthTech
applications
AI & Machine learning
AskAI Classifications
Labels
SaaS
Artificial Intelligence Software
Data Analytics Software
Linked Companies
HyperSpectral
$1M to $5M